Pharma Equity Group A/S

CPH-PEG
Copenhagen Stock Exchange
Healthcare Biotechnology
Global Rank
#35544
Country Rank
#116
Market Cap
23.19 M
Price
0.0189
Change (%)
1.27%
Volume
150,237

Pharma Equity Group A/S (CPH-PEG) Stock Split History

Date Split Ratio Multiple Cumulative multiple Type
11/01/2019 1:6.64 x0.1506024 x0.07794064 Reverse
10/29/2019 1:10 x0.1 x0.5175258 Reverse
10/10/2019 1.506:1 x1.506 x5.175258 Forward
02/24/2016 10:1 x10 x3.436426 Forward
12/27/2010 1:2.91 x0.3436426 x0.3436426 Reverse

Frequently Asked Questions

  • How much would Pharma Equity Group A/S stock be worth if it never split?
    If Pharma Equity Group A/S (stock symbol: CPH-PEG) had never undergone any stock splits, its price per share today would be approximately 0.00 USD. This calculation reflects the cumulative effect of all splits, including the most recent split (ratio: 1-for-6.64) that occurred on 11/01/2019.
  • Pharma Equity Group A/S (stock symbol: CPH-PEG) has undergone a total of five stock splits. The most recent split occurred on 11/01/2019. One share bought prior to the first split on 12/27/2010 would now equal 0.08 shares.
  • Pharma Equity Group A/S (stock symbol: CPH-PEG) has undergone five stock splits in its history. The most recent split, a 1-for-2.91 split, occurred on 11/01/2019. While future splits are not guaranteed, significant increases in stock price could prompt consideration for another split.

MarketCapWatch.com ranks all listed companies worldwide, providing unique insights into market capitalization across industries. As one of the most comprehensive ranking platforms, it covers companies of all sizes and sectors.

Ranking

Copyright © 2025. All rights reserved

Important Disclaimer: All content provided on this website, including hyperlinked pages, related applications, forums, blogs, social media accounts, and other platforms ("the Site"), is for general informational purposes only and sourced from third-party providers. We make no guarantees regarding the accuracy, completeness, or timeliness of the content.

None of the information presented constitutes financial, legal, or professional advice. Users should conduct their own research, evaluation, and verification before making any decisions. Investing and trading carry significant risks that may lead to substantial losses. Therefore, we strongly recommend consulting a qualified financial advisor before taking any action.